List of Certificates of Suitability (CEPs) for cep_2021_192___rev_02 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

Question

Looking for Certificates of Suitability (CEPs) for CEP 2021-192 - Rev 02 of Chunghwa Chemical Synthesis & Biotech Co., Ltd. Shu-lin Tw

score 20 · Accepted Answer

Chunghwa Chemical Synthesis & Biotech Co., Ltd. Shu-lin Tw, based in Taiwan, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

They are recognized for Chunghwa provides cost-effective APIs & advanced intermediates with complete DMF or COS, ensuring quality & reliable production.

One of their significant offerings is Everolimus, With antioxidant butylhydroxytoluene 2.0%, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2021-192 - Rev 02

This Chemical Type CEP, issued on February 22, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

Substance Number 2918 associated with this CEP further emphasizes

List of Certificates of Suitability (CEPs) for cep_2021_192___rev_02 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

Chunghwa Chemical Synthesis & Biotech

VISIT THE VIRTUAL BOOTH

Review portfolio & marketing content

CONTACT DETAILS

Google Map, LinkedIn, Emails...

EVENTS

Webinars & Exhibitions

PRESENTATION(s)

VIDEO(s)

DIGITAL CONTENT

5 CORPORATE CONTENT #SupplierSpotlight

19 NEWS #PharmaBuzz

ACTIVE PHARMA INGREDIENTS

KEY PRODUCTS

SERVICES

API Manufacturing

API & Drug Product Development

INSPECTIONS & REGISTRATIONS

Filters

CEP 2021-192 - Rev 02

Valid

Chemical

2024-02-22

2918

01

Looking for Certificates of Suitability (CEPs) for CEP 2021-192 - Rev 02 of Chunghwa Chemical Synthesis & Biotech Co., Ltd. Shu-lin Tw